Human genetics

Blood DNA changes linked to aging and disease progression in inflammatory bowel disease

Updated

Abstract

Essence

Blood patterns in inflammatory bowel disease were linked to epigenetic age acceleration and to long-term recurrence and active ulcerative colitis in some analyses.

Evidence

This was a peripheral blood DNA methylation cohort study with 8-year follow-up in 184 adults, plus replication in two independent IBD cohorts (adult n=377 and paediatric n=238), using Illumina 450K profiling and measures.

Caveat

Most prognostic signals were limited, with only one CpG associated with long-term recurrence, and the stronger ageing signal in active disease was seen in ulcerative colitis but not Crohn disease.

Simplified

Key numbers

68 of 146
Clinical Recurrence Rate
Short-term recurrence status in the discovery cohort.
669
Age Acceleration in Active
GrimAge U statistic for active vs. inactive patients.
3.233
Pace of Aging in Active
t-statistic for active vs. inactive patients.

Key figures

Fig. 1
vs control: aging signature values in blood samples
Highlights higher DNA methylation aging signature values in IBD patients compared to controls, spotlighting epigenetic age differences
439_2025_2779_Fig1_HTML
  • Panel 1
    values for IBD and control groups with a p-value of 0.003; IBD group appears to have higher median values
  • Panel 2
    values for IBD and control groups with a p-value of 0.004; IBD group shows higher median values
  • Panel 3
    values for IBD and control groups with a p-value of 0.008; IBD group has higher median values
Fig. 2
Crohn's disease vs control: aging signature values in blood samples
Highlights higher DNA methylation aging signature values in Crohn's disease compared to controls
439_2025_2779_Fig2_HTML
  • Panel 1
    values are visibly higher in Crohn's disease () compared to controls with p = 0.006
  • Panel 2
    values appear higher in CD than controls with p = 0.010
  • Panel 3
    values are higher in CD compared to controls with p = 0.012
  • Panel 4
    DNAmTLadjAge values show a difference between CD and controls with p = 0.021
  • Panel 5
    MI-EN TLadjAge values differ between CD and controls with p = 0.041
Fig. 3
vs control: aging signature values in blood samples
Highlights higher DNA methylation aging signature values in IBD patients compared to controls
439_2025_2779_Fig3_HTML
  • Panel 1
    values for IBD and control groups with a p-value of 1.78e-15; IBD group appears to have higher median values
  • Panel 2
    values for IBD and control groups with a p-value of 4.15e-09; IBD group appears to have higher median values
  • Panel 3
    values for IBD and control groups with a p-value of 9.84e-05; IBD group appears to have higher median values
Fig. 4
vs control: aging signature values in blood samples
Highlights higher DNA methylation age acceleration in CD compared to controls using three
439_2025_2779_Fig4_HTML
  • Panel DunedinPACE
    Mean values for CD and control groups with higher values visibly in CD
  • Panel AgeAccelGrim2
    Mean values for CD and control groups with higher values visibly in CD
  • Panel AgeAccelGrim
    Mean values for CD and control groups with higher values visibly in CD
Fig. 5
vs control: aging signature values in blood samples
Highlights higher DNA methylation aging signature values in UC compared to controls, indicating accelerated biological aging
439_2025_2779_Fig5_HTML
  • Panel 1
    values for Control and UC groups; UC appears to have higher median and range values
  • Panel 2
    values for Control and UC groups; UC shows higher median and wider range values
  • Panel 3
    values for Control and UC groups; UC has higher median and more outliers
1 / 5

Full Text

What this is

  • This research investigates () signatures related to aging and disease progression in inflammatory bowel disease (IBD).
  • It expands on prior findings by including 8-year clinical follow-up data from IBD patients and controls.
  • The study identifies significant epigenetic age acceleration in IBD patients compared to healthy controls, using advanced epigenetic clocks.

Essence

  • IBD patients exhibit accelerated biological aging as indicated by patterns, which may serve as biomarkers for disease monitoring and classification.

Key takeaways

  • One CpG site (cg03583111) is significantly hypermethylated in IBD patients with long-term clinical recurrence compared to those without. This site could serve as a potential biomarker for disease relapse.
  • IBD patients show significant epigenetic age acceleration, with measures from three epigenetic clocks (DunedinPACE, GrimAge, GrimAge2) indicating increased biological aging compared to controls.
  • Active ulcerative colitis (UC) patients exhibit higher age acceleration (GrimAge, U = 669, p = 0.003) and a faster pace of aging (DunedinPACE, t = 3.233, p = 0.002) compared to inactive disease.

Caveats

  • The study's sample size is relatively small, which may limit the generalizability of the findings. However, results were replicated in independent cohorts.
  • Heterogeneity in the patient population regarding disease location and treatment may confound results, necessitating further research in more homogeneous groups.

Definitions

  • DNA methylation (DNAm): A biochemical process that modifies DNA, influencing gene expression and associated with various diseases.
  • epigenetic clock: A biomarker that estimates biological age based on DNA methylation patterns, reflecting aging and disease states.

Simplified

Funding

Competing interests

0 of 5
authors report competing interests
5 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free